MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells

Mengru Cao, Masahiro Seike, Chie Soeno, +7

International Journal of Oncology

Cancer BiologyTumor BiologyEpithelial-mesenchymal TransitionTissue DevelopmentCancer Cell Biology +16

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

Nobuhiko Nishijima, Masahiro Seike, Chie Soeno, +7

International Journal of Oncology

PathologyCancer BiologyTumor BiologyRadiation OncologyCancer Research +15

Inhibition of ABCB1 Overcomes Cancer Stem Cell–like Properties and Acquired Resistance to MET Inhibitors in Non–Small Cell Lung Cancer

Teppei Sugano, Masahiro Seike, Rintaro Noro, +9

Molecular Cancer Therapeutics

Cancer BiologyTumor BiologyCancer Cell BiologyAnti-cancer AgentMet Inhibitors +14

miR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma

Kazuo Yamamoto, Masahiro Seike, Susumu Takeuchi, +6

Oncology Reports

Histone deacetylase inhibitor enhances sensitivity of non‐small‐cell lung cancer cells to 5‐FU/S‐1 via down‐regulation of thymidylate synthase expression and up‐regulation of p21^waf1/cip1 expression

Rintaro Noro, Akihiko Miyanaga, Yuji Minegishi, +7

Cancer Science

Histone Deacetylase InhibitorSeveral HistoneCancer BiologyTumor BiologyCancer Cell Biology +18

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation

Rintaro Noro, Masahiro Seike, Fenfei Zou, +11

BMC Cancer

Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling

Tetsuya Okano, Masahiro Seike, Hidehiko Kuribayashi, +4

International Journal of Oncology

AsthmaAcute Lung InjuryInflammatory Lung DiseaseAdvanced Lung DiseaseLung Inflammation +25

HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner

Hideaki Mizutani, Tetsuya Okano, Yuji Minegishi, +8

Oncology Letters

Cancer BiologyTumor BiologyCell RegulationMesenchymal TransitionCancer Cell Biology +16

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

Masaru Matsumoto, Masahiro Seike, Rintaro Noro, +7

BMC Cancer

Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules

Tsuneo Shimokawa, Masahiro Seike, Chie Soeno, +9

British Journal of Cancer